Cargando…
The “Brittle Response” to Parkinson’s Disease Medications: Characterization and Response to Deep Brain Stimulation
OBJECTIVE: Formulate a definition and describe the clinical characteristics of PD patients with a “brittle response” (BR) to medications versus a “non-brittle response” (NBR), and characterize the use of DBS for this population. METHODS: An UF IRB approved protocol used a retrospective chart review...
Autores principales: | Martinez-Ramirez, Daniel, Giugni, Juan, Vedam-Mai, Vinata, Shukla, Aparna Wagle, Malaty, Irene A., McFarland, Nikolaus R., Rodriguez, Ramon L., Foote, Kelly D., Okun, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986256/ https://www.ncbi.nlm.nih.gov/pubmed/24733172 http://dx.doi.org/10.1371/journal.pone.0094856 |
Ejemplares similares
-
Tissue Response to Deep Brain Stimulation and Microlesion: A Comparative Study
por: Vedam‐Mai, Vinata, et al.
Publicado: (2016) -
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
por: Klann, Emily M., et al.
Publicado: (2022) -
An Eight-Year Clinic Experience with Clozapine Use in a Parkinson’s Disease Clinic Setting
por: Hack, Nawaz, et al.
Publicado: (2014) -
Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2014) -
Update on deep brain stimulation in Parkinson’s disease
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2015)